· Adds propriEtary Technologies for response prediction and Drug efficacy and safety assessment; especially in Key indication area oncology · Adds fast growing business with an expected revenue of € …
News
Rapid Micro Biosystems Partners with Life Technologies Corporation on Automated Microbial Detection– Growth Direct™ System
Businesses team to accelerate microbial detection and identification. Bedford, MA - (February 8, 2011)– Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial …
Concert Pharmaceuticals Enters Into a Cooperative Research and Development Agreement with Walter Reed Army Institute of Research to Evaluate Neuroprotective Drug Compound
Advances Concert’s R&D for Novel Drugs to Treat Seizure-Generating Diseases and Injuries February 2, 2011 Lexington, MA -- Concert Pharmaceuticals, Inc. today announced that it has entered into a …
Interleukin (IL)-12 Secretion Can Predict Potency of Argos Therapeutics´ Arcelis™ Dendritic Cell (DC) Immunotherapy and Can Be Used as Potency Marker in Phase 3 Clinical Trial
—In Vitro Results Published in Journal of Immunotherapy Demonstrate That Potency of Mature CD40L RNA Electroporated DCs Correlates with IL-12 Secretion by Tracking Multifunctional CD8(+)/CD28(+) …
CyDex Pharmaceuticals Approves Merger with Ligand Pharmaceuticals
Transaction Closed Today Expected to Accelerate Development of CyDex’s Captisol® Franchise LENEXA, Kansas – January 26, 2011 – CyDex Pharmaceuticals, Inc. today announced that its stockholders have …
MediGene Adds Romania and Bulgaria to Existing Partnership Agreement with Meditrina for the Commercialization of Veregen®
Martinsried/Munich, January 25, 2011. The biotech company MediGene AG (Frankfurt, Prime Standard) announced today that its existing partnership with Meditrina Pharmaceuticals Ltd., Greece, for the …